A Randomized Controlled Trial of Late Conversion from CNI-Based to Sirolimus-Based Immunosuppression Following Renal Transplantation-Reference-Cited by-同舟云学术

A Randomized Controlled Trial of Late Conversion from CNI-Based to Sirolimus-Based Immunosuppression Following Renal Transplantation

Published:2005-10 Issue:10 Volume:5 Page:2496-2503
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Watson Christopher J. E.,Firth John,Williams Paul F.,Bradley John R.,Pritchard Nicholas,Chaudhry Afzal,Smith Jane C.,Palmer Christopher R.,Bradley J. Andrew

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2005.01055.x/fullpdf

Reference33 articles.

1. CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS

2. CYCLOSPORIN IN THERAPEUTIC DOSES INCREASES RENAL ALLOGRAFT VASCULAR RESISTANCE

3. CONVERSION TO MYCOPHENOLATE MOFETIL IN CONJUNCTION WITH STEPWISE WITHDRAWAL OF CYCLOSPORINE IN STABLE RENAL TRANSPLANT RECIPIENTS1

4. Cyclosporin nephrotoxicity following cardiac transplantation

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic options for the prevention of kidney transplant rejection: the evidence to date;Expert Opinion on Pharmacotherapy;2022-07-19

2. 5‐Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients;Transplant International;2020-12-31

3. Opportunistic infections after conversion to belatacept in kidney transplantation;Nephrology Dialysis Transplantation;2020-02-01

4. Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results;Seminars in Hematology;2019-07

5. mTOR Inhibitors;Kidney Transplantation - Principles and Practice;2019